Profile
Full Name
ARS Pharmaceuticals, Inc.Ticker Symbol
SPRYExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
December 4, 2020Indexes
Not includedWebsite
http://ars-pharma.comEmployees
155Key Details
Price
$14.88(0.00%)
Market cap
$1.46B(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$89.15M(+297063.33% YoY)
Annual EPS
$0.08(+114.04% YoY)
PE ratio
212.57
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
ARS Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 7, 25 Scotiabank
Sector OutperformJan 14, 25 Raymond James
Strong BuyJan 13, 25 Leerink Partners
OutperformOct 8, 24 Cantor Fitzgerald
OverweightSep 20, 24 Leerink Partners
OutperformSep 16, 24 Cantor Fitzgerald
OverweightSep 9, 24 Cantor Fitzgerald
OverweightAug 20, 24 Cantor Fitzgerald
OverweightAug 13, 24 Raymond James
Strong BuyJul 25, 24 Raymond James
OutperformInstitutional Ownership
- What is the ticker symbol for ARS Pharmaceuticals?
- Does ARS Pharmaceuticals pay dividends?
- What sector is ARS Pharmaceuticals in?
- What industry is ARS Pharmaceuticals in?
- What country is ARS Pharmaceuticals based in?
- When did ARS Pharmaceuticals go public?
- Is ARS Pharmaceuticals in the S&P 500?
- Is ARS Pharmaceuticals in the NASDAQ 100?
- Is ARS Pharmaceuticals in the Dow Jones?
- When was ARS Pharmaceuticals's last earnings report?
- When does ARS Pharmaceuticals report earnings?
- Should I buy ARS Pharmaceuticals stock now?
What is the ticker symbol for ARS Pharmaceuticals?
The ticker symbol for ARS Pharmaceuticals is NASDAQ:SPRY
Does ARS Pharmaceuticals pay dividends?
No, ARS Pharmaceuticals does not pay dividends
What sector is ARS Pharmaceuticals in?
ARS Pharmaceuticals is in the Healthcare sector
What industry is ARS Pharmaceuticals in?
ARS Pharmaceuticals is in the Biotechnology industry
What country is ARS Pharmaceuticals based in?
ARS Pharmaceuticals is headquartered in United States
When did ARS Pharmaceuticals go public?
ARS Pharmaceuticals's initial public offering (IPO) was on December 4, 2020
Is ARS Pharmaceuticals in the S&P 500?
No, ARS Pharmaceuticals is not included in the S&P 500 index
Is ARS Pharmaceuticals in the NASDAQ 100?
No, ARS Pharmaceuticals is not included in the NASDAQ 100 index
Is ARS Pharmaceuticals in the Dow Jones?
No, ARS Pharmaceuticals is not included in the Dow Jones index
When was ARS Pharmaceuticals's last earnings report?
ARS Pharmaceuticals's most recent earnings report was on Mar 20, 2025
When does ARS Pharmaceuticals report earnings?
The next expected earnings date for ARS Pharmaceuticals is May 9, 2025
Should I buy ARS Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions